You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for THIAMINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


THIAMINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aspiro THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 218471 ANDA Camber Pharmaceuticals, Inc. 31722-363-32 25 VIAL, MULTI-DOSE in 1 TRAY (31722-363-32) / 2 mL in 1 VIAL, MULTI-DOSE (31722-363-31) 2024-11-06
Caplin THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 215692 ANDA Caplin Steriles Limited 65145-129-25 25 VIAL, MULTI-DOSE in 1 CARTON (65145-129-25) / 2 mL in 1 VIAL, MULTI-DOSE (65145-129-01) 2024-05-20
Caplin THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 215692 ANDA Armas Pharmaceuticals Inc. 72485-507-25 25 VIAL, MULTI-DOSE in 1 CARTON (72485-507-25) / 2 mL in 1 VIAL, MULTI-DOSE (72485-507-01) 2023-05-22
Caplin THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 215692 ANDA NorthStar Rx LLC 72603-139-25 25 VIAL, MULTI-DOSE in 1 CARTON (72603-139-25) / 2 mL in 1 VIAL, MULTI-DOSE (72603-139-01) 2023-04-20
Dr Reddys THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 080571 ANDA Henry Schein, Inc. 0404-9799-20 1 VIAL, MULTI-DOSE in 1 BAG (0404-9799-20) / 2 mL in 1 VIAL, MULTI-DOSE 2024-09-17
Dr Reddys THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 080571 ANDA Dr. Reddy's Laboratories Inc. 43598-050-25 25 VIAL, MULTI-DOSE in 1 CARTON (43598-050-25) / 2 mL in 1 VIAL, MULTI-DOSE (43598-050-11) 2023-03-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Thiamine Hydrochloride

Last updated: July 29, 2025

Introduction

Thiamine hydrochloride, commonly known as vitamin B1 hydrochloride, is a vital water-soluble vitamin used extensively in the pharmaceutical, nutraceutical, and food industries. It plays a crucial role in carbohydrate metabolism, neurology, and energy production. Its use extends from prophylactic treatments of thiamine deficiency to therapy for conditions such as beriberi, Wernicke’s encephalopathy, and alcoholism-associated deficiencies. Ensuring a reliable supply of high-quality thiamine hydrochloride is critical for pharmaceutical manufacturers, distributors, and healthcare providers. This article explores primary suppliers worldwide, including key manufacturers, geographic regions, and considerations for procurement.


Global Market Overview

The global demand for thiamine hydrochloride has been steadily rising, driven by increasing awareness of vitamin deficiency health issues, growing use of nutraceuticals, and expanding pharmaceutical applications. The Asia-Pacific region dominates production and supply, particularly China and India, known for their large-scale pharmaceutical manufacturing sectors. Europe and North America primarily serve as markets for finished products, with supply chains relying on imports from manufacturing hubs.


Major Manufacturers of Thiamine Hydrochloride

Several leading chemical and pharmaceutical companies dominate the production of thiamine hydrochloride. Their ability to provide high-grade APIs (Active Pharmaceutical Ingredients) depends on factors including manufacturing capacity, quality standards, regulatory compliance, and distribution networks.

1. Sun Pharmaceutical Industries Ltd
Based in India, Sun Pharma is among the largest producers of vitamins, including thiamine hydrochloride. They manufacture APIs in compliance with international quality standards like GMP (Good Manufacturing Practice) and have extensive distribution channels spanning globally. Their production facilities in India are certified by regulatory agencies such as the US FDA and European EMA.

2. Hubei Huida Pharmaceutical Co., Ltd.
A Chinese pharmaceutical company specializing in vitamin APIs, Hubei Huida offers a broad portfolio including thiamine hydrochloride. The company leverages China's large-scale production capabilities, meeting both domestic and international standards. Their products are used in pharmaceutical and nutraceutical formulations worldwide.

3. Zhejiang Skyblue Chemical Co., Ltd.
Another significant Chinese manufacturer, Skyblue Chemical, produces high-purity thiamine hydrochloride with a focus on export markets. Their facilities maintain compliance with cGMP and ISO standards, ensuring reliable supply and regulatory acceptance.

4. Jiangsu Rixing Pharmaceutical Co., Ltd.
This Chinese API manufacturer offers a variety of vitamins, including thiamine hydrochloride, with certifications such as ISO, GMP, and USP compatibility. Their vertical integration supports cost-effective production, making them a noteworthy supplier.

5. Katayama Chemical Industries Ltd.
A Japanese chemical manufacturer, Katayama produces pharmaceutical-grade vitamins and APIs. Their focus on research, development, and quality control ensures high-purity thiamine hydrochloride meets stringent pharmaceutical specifications.

6. Zhejiang Medicine Co., Ltd.
A leading pharmaceutical entity in China, Zhejiang Medicine manufactures a range of vitamins and APIs. Their products are used extensively domestically and internationally, with certifications that enable entry into regulated markets.

7. Akorn, Inc.
U.S.-based pharmaceutical producer, Akorn, sources various vitamin APIs, including thiamine hydrochloride, to meet North American market demands. Their manufacturing facilities adhere to cGMP and are registered with the FDA.


Regional Suppliers and Considerations

Asia-Pacific Region
Asia remains the hub for manufacturing thiamine hydrochloride due to cost efficiency and large-scale production capacities. Chinese, Indian, and Japanese companies dominate this market, with exports to North America, Europe, and Africa.

Europe and North America
These regions primarily import API formulations from Asia but also have local manufacturers that meet strict regulatory standards. For instance, certain European companies produce pharmaceutical-grade APIs for niche markets, emphasizing quality assurance.

Emerging Suppliers
Some Southeast Asian and Middle Eastern companies are expanding their API portfolios, offering competitive prices and establishing regulatory compliance to serve growing markets.


Procurement Considerations

Regulatory Compliance
Suppliers must adhere to GMP, ISO certifications, and meet pharmacopoeial standards (USP, EP, JP) for pharmaceutical-grade thiamine hydrochloride. Regulatory compliance facilitates registration in various jurisdictions.

Quality Assurance and Certification
Given the sensitive nature of APIs, buyers should verify quality certifications, batch consistency, and purity levels (typically >98%). Third-party audits and testing reports are recommended before bulk procurement.

Pricing and Supply Chain Stability
Pricing varies based on purity, volume, and supplier reputation. Long-term contracts often ensure supply stability amid fluctuating market dynamics.

Lead Times
Manufacturing lead times depend on order complexity, quantity, and regulatory clearance. Advanced planning and supplier relationships are critical for timely procurement.


Emerging Trends and Market Dynamics

The thiamine hydrochloride market is influenced by global health policies emphasizing nutrition and disease management. The COVID-19 pandemic increased emphasis on immune-supportive nutrients, impacting demand. Regulatory pressures for quality standards continue to rise, pressing suppliers to maintain stringent manufacturing processes. Alternative sourcing strategies, such as local manufacturing and R&D collaborations, are gaining traction among pharmaceutical companies seeking supply resilience.


Key Players Summary Table

Manufacturer Location Certifications Product Focus Key Markets
Sun Pharmaceutical Industries Ltd India GMP, ISO, USP API, bulk vitamins Global, Asia-Pacific
Hubei Huida Pharmaceutical Co., Ltd. China GMP, ISO Vitamins, APIs Global
Zhejiang Skyblue Chemical Co., Ltd. China GMP, ISO, USP Vitamins / APIs Global
Jiangsu Rixing Pharmaceutical Co., Ltd. China GMP, ISO, USP Vitamins / APIs Global
Katayama Chemical Industries Ltd. Japan cGMP, ISO, JP High-purity APIs Asia, global
Zhejiang Medicine Co., Ltd. China GMP, ISO Pharmaceuticals and APIs Asia, Global
Akorn, Inc. USA cGMP, FDA Pharmaceutical APIs North America

Conclusion

Reliable procurement of thiamine hydrochloride depends on engaging reputable suppliers who comply with international quality standards and can meet consistent supply demands. The dominant players are concentrated in Asia, with certifications supporting export into regulated markets. Pharmaceutical companies should conduct thorough qualification processes, including quality audits and reviewing certifications, to mitigate risks and secure a stable supply chain for this essential vitamin.


Key Takeaways

  • The majority of pharmaceutical-grade thiamine hydrochloride is supplied by Asian manufacturers, primarily in China and India, leveraging large-scale production efficiencies.
  • Ensuring suppliers have GMP, ISO, and pharmacopoeial certifications is essential for regulatory compliance and product quality.
  • Long-term relationships and clear contractual agreements help mitigate supply risks amid market fluctuations.
  • Procurement strategies should include due diligence, testing, and verification to maintain high purity standards.
  • Market trends indicate rising demand linked to global health initiatives, emphasizing the importance of supply chain resilience.

FAQs

1. What qualities should I look for in a supplier of thiamine hydrochloride?
Suppliers should hold GMP and ISO certifications, produce API with purity levels exceeding 98%, and have proven compliance with pharmacopoeial standards (USP, EP, JP). Audits and testing reports are essential for verification.

2. Which regions dominate the production of thiamine hydrochloride?
China and India are the primary manufacturing hubs, owing to their large-scale chemical production infrastructure. Europe and North America mainly serve as markets, sourcing from these regions.

3. How does regulatory compliance influence supplier selection?
Regulatory compliance ensures API acceptance by health authorities worldwide. Suppliers compliant with GMP and FDA or EMA standards facilitate smoother registration and market entry.

4. Are there alternative sources for thiamine hydrochloride?
Emerging suppliers in Southeast Asia and the Middle East are entering the market, offering competitive pricing and ISO/GMP-certified products, though their market penetration is still developing.

5. What are the main challenges in sourcing thiamine hydrochloride?
Challenges include maintaining quality consistency, navigating regulatory approvals, managing supply chain disruptions, and ensuring cost-effectiveness in procurement.


References

  1. [1] Market research reports on vitamin APIs and global procurement trends.
  2. [2] Manufacturer websites and product catalogues.
  3. [3] Regulatory agency guidelines (FDA, EMA, WHO).
  4. [4] Industry publications on pharmaceutical raw material sourcing strategy.
  5. [5] Trade and customs data on vitamin API exports.

Note: The information in this article is based on publicly available data up to 2023 and is intended for informational purposes. Buyers should conduct their own due diligence.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.